You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Senores Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for SENORES PHARMS, and what generic and branded alternatives to SENORES PHARMS drugs are available?

SENORES PHARMS has thirteen approved drugs.



Summary for Senores Pharms
US Patents:0
Tradenames:12
Ingredients:12
NDAs:13

Drugs and US Patents for Senores Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Senores Pharms BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 214088-001 Apr 7, 2022 AA RX No No ⤷  Subscribe ⤷  Subscribe
Senores Pharms AMPHETAMINE SULFATE amphetamine sulfate TABLET;ORAL 212901-002 May 22, 2020 AA RX No No ⤷  Subscribe ⤷  Subscribe
Senores Pharms TOPIRAMATE topiramate CAPSULE;ORAL 218642-002 Oct 10, 2024 AB RX No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.